Predict your next investment

Parkwalk Advisors company logo
Venture Capital
FINANCE | Investment Firms & Funds
parkwalkadvisors.com

See what CB Insights has to offer

Investments

131

Portfolio Exits

6

Funds

23

About Parkwalk Advisors

Parkwalk Advisors is an EIS growth fund manager focused on university spin-outs, particularly high-growth technology companies. The bulk of the funds under management come from high net worth individuals (HNWs), family offices, and private wealth platforms. Parkwalk Advisors also helps small and medium-size public and private companies access capital outside the Parkwalk fund structures.

Parkwalk Advisors Headquarter Location

University House 11-13 Lower Grosvenor Place

London, England, SW1W 0EX,

United Kingdom

+44 20 7759 2285

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Parkwalk Advisors Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Parkwalk Advisors Rank

Latest Parkwalk Advisors News

Parkwalk Advisors: Meet the UK’s most active investor in academic spinouts

Jul 13, 2022

Parkwalk Advisors: Meet the UK’s most active investor in academic spinouts The UK has a thriving spinout ecosystem. Innovative technologies cultivated in academia have gone on to raise millions in capital and exit in blockbuster IPOs. But who is the most active investor in UK university spinouts? According to a recent report by data platform Beauhurst, that accolade is shared by London-based Parkwalk Advisors and Scottish Enterprise, a government body. Each organisation made 31 equity investments into UK spinouts in 2021. Among Parkwalk’s spinout investments was its participation in a £34.5m round for University of Cambridge therapeutics startup PhoreMost. It also invested in the University of Oxford diagnostics spinout Brainomix’s £17m funding round. Founded in 2009, Parkwalk was set up by Moray Wright, CEO, and its chief investment officer Alastair Kilgour. Each of them previously worked at financial services firm Lazard, where they both personally invested in spinouts. “That sort of worked… they weren’t fantastic but we were I guess slightly dopey angel investors,” Wright tells UKTN. The pair launched Parkwalk to democratise access to spinouts, which Wright says was previously an opportunity limited to specialist venture capital firms. ‘Early-stage investing is difficult’ Parwalk always invests as a syndicate investor, investing up to £20m into a single company. In total, it has invested £362m in more than 150 companies. The firm employs 23 people. Alongside its own funds, Parkwalk also works with Cambridge, Oxford, Bristol and Imperial College universities to manage their own funds. If they prove successful and have a commercial application, Parkwalk will then invest from its larger funds into the spinouts. “Early-stage investing is difficult,” says Wright. “You can be too early to market you can be too late to the market, you can have rubbish management. You’ve got to have a little bit of serendipity in there as well. So you need a few things to align for it all to work.” Parkwalk is part of London-based intellectual property business IP Group , which is listed on the London Stock Exchange and invests in technology companies. Better than bonds Wright says that investing in spinouts provides an alternative to bonds and “other rubbish” with low returns for investors, a point underscored by current inflation levels. But it’s the UK’s world-famous institutions, such as the University of Cambridge, that Wright says is the biggest draw, attracting people from all over the world to solve complex problems. “I think it’d be quite nice if we could try and build some decent big companies here in the UK that can employ a lot of people and have a knock-on effect,” says Wright. As part of his job, Wright is exposed to bleeding-edge technology. How does he decide whether to invest? “You’ve got to be careful not to fall in love with a cool tech that’s just the most amazing thing I’ve ever seen. But if it hasn’t got a market it hasn’t got a market,” Wright says. Investments Parkwalk’s investments are all in academic spinouts, but the sectors that they hail from our wide-ranging: its portfolio includes startups operating in quantum computing, medtech, AI, agtech and many more.

Parkwalk Advisors Investments

131 Investments

Parkwalk Advisors has made 131 investments. Their latest investment was in Psyomics as part of their Unattributed VC - III on June 6, 2022.

CBI Logo

Parkwalk Advisors Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/21/2022

Unattributed VC - III

Psyomics

$2.94M

No

5

5/26/2022

Series B

MoA Technology

$44M

No

1

5/2/2022

Seed VC

Ceryx Medical

$4.7M

No

1

4/11/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

3/15/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/21/2022

5/26/2022

5/2/2022

4/11/2022

3/15/2022

Round

Unattributed VC - III

Series B

Seed VC

Series A

Seed VC

Company

Psyomics

MoA Technology

Ceryx Medical

Subscribe to see more

Subscribe to see more

Amount

$2.94M

$44M

$4.7M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

1

1

10

10

Parkwalk Advisors Portfolio Exits

6 Portfolio Exits

Parkwalk Advisors has 6 portfolio exits. Their latest portfolio exit was YASA on July 22, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/22/2021

Acquired

$99M

9

6/22/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/12/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/23/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/25/2014

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/22/2021

6/22/2021

12/12/2019

7/23/2019

3/25/2014

Exit

Acquired

Acquired

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

9

10

10

10

10

Parkwalk Advisors Fund History

23 Fund Histories

Parkwalk Advisors has 23 funds, including University of Cambridge Enterprise Fund V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/1/2017

University of Cambridge Enterprise Fund V

Early-Stage Venture Capital

Closed

1

12/1/2016

University of Cambridge Enterprise Fund IV

Early-Stage Venture Capital

Closed

$3.81M

1

2/28/2015

University of Oxford Isis Fund II

Early-Stage Venture Capital

Closed

$3.01M

1

10/31/2014

The University of Oxford Isis Fund I

Subscribe to see more

Subscribe to see more

$99M

10

9/1/2014

University of Cambridge Enterprise Fund III

Subscribe to see more

Subscribe to see more

10

Closing Date

1/1/2017

12/1/2016

2/28/2015

10/31/2014

9/1/2014

Fund

University of Cambridge Enterprise Fund V

University of Cambridge Enterprise Fund IV

University of Oxford Isis Fund II

The University of Oxford Isis Fund I

University of Cambridge Enterprise Fund III

Fund Type

Early-Stage Venture Capital

Early-Stage Venture Capital

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Closed

Closed

Closed

Subscribe to see more

Subscribe to see more

Amount

$3.81M

$3.01M

$99M

Sources

1

1

1

10

10

Parkwalk Advisors Team

2 Team Members

Parkwalk Advisors has 2 team members, including current Chief Executive Officer, Moray Wright.

Name

Work History

Title

Status

Moray Wright

Chief Executive Officer

Current

Alastair H L Kilgour

MF Global, and Lazard Frères & Co.

Chief Investment Officer

Current

Name

Moray Wright

Alastair H L Kilgour

Work History

MF Global, and Lazard Frères & Co.

Title

Chief Executive Officer

Chief Investment Officer

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.